HR 6561 United States House · 119th Congress

PREVENT HPV Cancers Act of 2025

The PREVENT HPV Cancers Act of 2025 creates a national public awareness campaign to boost HPV vaccination rates and combat misinformation, targeting communities disproportionately affected by HPV-related cancers (including Black and Hispanic women, rural populations, and men facing higher oropharyngeal cancer risks). It authorizes $5 million annually from 2026-2030 for evidence-based media, culturally tailored materials, and partnerships with health providers, schools, and community organizations to increase vaccination completion among adolescents (9-12 years old, the optimal age group). The bill also increases annual funding for the Breast and Cervical Cancer Early Detection Program to $300 million starting in 2026, coordinating vaccination efforts with existing screening initiatives. It requires the CDC to consult with health experts and community groups to develop effective messaging about vaccine safety, benefits, and recommended age ranges. The campaign aims to address current gaps, such as the 63% HPV vaccine completion rate among teens and disparities in cancer outcomes.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
President
Introduced Dec 10, 2025 Last action Dec 10, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Dec 10, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Dec 10, 2025
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors

Sponsors